Detailed analysis of serum lipids and lipoproteins from Japanese type III hyperlipoproteinemia with apolipoprotein E2/2 phenotype

Clinica Chimica Acta

Volumn 348, Issue 1-2, 2004, Pages 35-40

  Todo, Yasuhiro ^a   Kobayashi, Junji ^a   Higashikata, Toshinori ^a   Kawashiri, Masaaki ^a   Nohara, Atsushi ^a   Inazu, Akihiro ^a   Koizumi, Junji ^a   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Apo E C III ratio; Ultracentrifugation; VLDL C TG ratio

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA TYPE 3; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; ULTRACENTRIFUGATION;

APOLIPOPROTEIN E2; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE III; JAPAN; LIPIDS; MALE; MIDDLE AGED; PHENOTYPE; SEX FACTORS; TRIGLYCERIDES; ULTRACENTRIFUGATION;

EID: 4444366770     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.04.018     Document Type: Article

References (27)

1. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630
2. Mahley R.W., Rall S.C. Jr. Apolipoprotein E: far more than a lipid transporter protein. Annu. Rev. Genomics Hum. Genet. 01:2000;507-537
3. Mahley R.W., Rall S.C. Jr. Type III hyperlipoproteinemia: the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. Scriver C.R., Beaudet A.L., Sly W.S., Valle D., Childs B., Kinzler K.W., Vogelstein B. The metabolic and molecular bases of inherited disease. vol. 2:2001;2835-2862 McGraw-Hill, New York
4. Weisgraber K.H., Innerarity T.L., Mahley R.W. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J. Biol. Chem. 257:1982;2518-2521
5. Utermann G., Pruin N., Steinmetz A. Polymorphism of apolipoprotein E: III. Effect of a single polymorphic gene locus on plasma lipid concentrations in man. Clin. Genet. 15:1979;63-72
6. Utermann G., Vogelberg K.H., Steinmetz A., Schoenborn W., Pruin N., Jaeschke M., et al. Polymorphism of apolipoprotein E: II. Genetics of hyperlipoproteinemia type III. Clin. Genet. 15:1979;37-62
7. Utermann G., Hees M., Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature. 269:1977;604-607
8. Hagberg J.M., Wilund K.R., Ferrell R.E. APO E gene and gene-environment effects on plasma lipoprotein-lipid concentrations. Physiol. Genomics. 4:2000;101-108
9. Morganroth J., Levy R.I., Fredrickson D.S. The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. Ann. Intern. Med. 82:1975;158-174
10. Feussner G., Wagner A., Kohl B., Ziegler R. Clinical features of type III hyperlipoproteinemia: analysis of 64 patients. Clin. Investig. 71:1993;362-366
11. Dyerberg J. Type 3 hyperlipoproteinemia with low plasma thyroxine binding globulin. Metabolism. 18:1969;50-57
12. Fredrickson DS, Levy RI, Lees RS. Fat transport in lipoproteins - an integrated approach to mechanisms and disorders. N Eng J Med 1967; 276 34-44, 94-103, 148-56, 215-25, 273-81.
13. Mahley R.W., Huang Y., Rall S.C. Patheogenesis of type III hyperlipoproteinemia: questions, quandaries, and paradoxes. J. Lipid Res. 40:1999;1933-1949
14. Eto M., Watanabe K., Ishii K. A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populations. Clin. Genet. 30:1986;422-427
15. Eto M., Nakata M., Iwashima Y., Watanabe K., Ikoda A., Kaka K. Type III hyperlipoproteinemia with apolipoprotein E2/2 genotype in Japan. Clin. Genet. 61:2002;416-422
16. Hata Y., Mabuchi H., Saito Y., et al. Report of the Japan Atherosclerosis Society (JAS) guideline for diagnosis and treatment of hyperlipidemia in Japanese adults. J. Atheroscler. Thromb. 9:2002;1-27
17. Havel R.L., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1955;1345-1353
18. Nakajima K., Saito T., Tamura A., Suzuki M., Nakano T., Adachi M., et al. Cholesterol in remnant like lipoproteins in human serum using monoclonal anti-apoB-100 and anti-apo A-I immunoaffinity mixed gels. Clin. Chim. Acta. 223:1993;53-71
19. Matsunaga A., Sasaki J., Moriyama K., Arakawa F., Takada Y., Nishi K., et al. Population frequency of apo E5 (Glu3→Lys) and E7 (Glu244→Lys) variants in western Japan. Clin. Genet. 48:1995;93-99
20. Moriyama K., Sasaki J., Matsunaga A., Arakawa F., Takada Y., Araki K., et al. Apolipoprotein E1 Lys 146 Glu with type III hyperlipoproteinemia. Biochem. Biophys. Acta. 1128:1992;58-64
21. Brewer H.B. Jr., Zech L.A., Gregg R.E., Schwartz D., Schaefer E.J. NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment. Ann. Intern. Med. 98:1983;623-640
22. Feussner G., Feusssner V., Hoffmann M.M., Lohrmann J., Wieland H., Marz W. Molecular basis of type III hyperlipoproteinemia in Germany. Human Mutat. 11:1998;417-423
23. Janus E.D., Grant S., Lincott V.J., Wardell M.R. Apolipoprotein E phenotypes in hyperlipidemic patients and their implications for treatment. Atherosclerosis. 57:1985;249-266
24. Kushwaha R.S., Hazzard W.R., Wahl P.W., Hoover J.J. Type III hyperlipoproteinemia: diagnosis in whole plasma by apolipoprotein-E immunoassay. Ann. Intern. Med. 87:1977;509-516
25. Havel R.J., Kane J.P. Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 70:1973;2015-2019
26. Sakai N., Uchida Y., Ohashi K., Hibuse T., Saika Y., Tomari Y., et al. Measurement of fasting serum apoB-48 concentrations in normolipidemic and hyperlipidemic subjects by ELISA. J. Lipid Res. 44:2003;1256-1262
27. Wang T., Nakajima K., Leary E.T., Warnick G.R., Cohn J.S., Hopkins P.N., et al. Ratio of remnant-like particle-cholesterol to serum total triglycerides is an effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia. Clin. Chem. 45:1999;1981-1987